雌激素
雌激素受体
生物
重编程
疾病
雌激素受体α
发病机制
组织蛋白酶
下调和上调
调解人
认知功能衰退
组织蛋白酶D
胶质增生
神经炎症
内分泌学
神经退行性变
受体
神经科学
小胶质细胞
信号转导
内科学
医学
生物信息学
雌激素受体
组织蛋白酶
癌症研究
基因表达调控
探地雷达
选择性雌激素受体调节剂
免疫学
单胺类
作者
Renzhi Yang,Lin Shao,Fang Huang,Ying He,Meng Yuan,Qilong Wu,Sen Lin,Kai Guo,Hongsheng Zhang
标识
DOI:10.1186/s12974-026-03970-5
摘要
Alzheimer's disease (AD) exhibits a pronounced sex bias, with women facing disproportionately higher risk and more severe pathology. Postmenopausal estrogen decline is implicated in this vulnerability, yet the molecular mechanisms linking estrogen loss to AD pathogenesis remain incompletely understood. Here, we demonstrate that ovariectomy (OVX) in female 5xFAD mice significantly exacerbates amyloid-β (Aβ) pathology, cognitive deficits, neuroinflammation, and reduces synaptic markers. Pharmacological blockade of estrogen receptor signaling recapitulated these effects, confirming their dependence on estrogen receptor pathways. Single-nucleus RNA sequencing (snRNA-seq) revealed widespread transcriptional reprogramming across brain cell types following estrogen deprivation, with prominent upregulation of the lysosomal protease cathepsin S (Ctss) and the AD risk gene ApoE. Remarkably, partial genetic reduction of CTSS prevented OVX-induced Aβ accumulation, glial activation, and synaptic decline in female 5xFAD mice, establishing CTSS as a critical downstream mediator of estrogen deficiency-driven pathology. Our findings provide mechanistic insight into sex-biased AD vulnerability and identify CTSS as a promising therapeutic target for mitigating AD risk in postmenopausal women.
科研通智能强力驱动
Strongly Powered by AbleSci AI